Wells Fargo’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.53M Buy
170,270
+77,229
+83% +$831K ﹤0.01% 3393
2026
Q1
$787K Sell
93,041
-58,475
-39% -$640K ﹤0.01% 3878
2025
Q4
$1.71M Buy
151,516
+39,389
+35% +$488K ﹤0.01% 3575
2025
Q3
$1.68M Buy
112,127
+6,661
+6% +$97K ﹤0.01% 3441
2025
Q2
$1.49M Buy
105,466
+2,809
+3% +$50.1K ﹤0.01% 3437
2025
Q1
$2.47M Buy
102,657
+59,007
+135% +$2.08M ﹤0.01% 2999
2024
Q4
$1.63M Buy
43,650
+10,232
+31% +$477K ﹤0.01% 3350
2024
Q3
$1.67M Sell
33,418
-1,764
-5% -$68.6K ﹤0.01% 3173
2024
Q2
$1.22M Sell
35,182
-427
-1% -$16.9K ﹤0.01% 3371
2024
Q1
$1.95M Buy
35,609
+11,321
+47% +$561K ﹤0.01% 2993
2023
Q4
$1.04M Sell
24,288
-64,993
-73% -$2.02M ﹤0.01% 3409
2023
Q3
$2.32M Buy
89,281
+31,434
+54% +$653K ﹤0.01% 2691
2023
Q2
$1.38M Sell
57,847
-18,047
-24% -$311K ﹤0.01% 3203
2023
Q1
$1.04M Buy
75,894
+72,831
+2,378% +$1.16M ﹤0.01% 3348
2022
Q4
$42.5K Buy
+3,063
New +$43.3K ﹤0.01% 4939

Other funds holding BHVN

Wells Fargo's BHVN Position: Q2 2026 in Review

Wells Fargo increased its Biohaven (BHVN) stake by 83% in Q2 2026, buying an estimated $831K and bringing the position to 170,270 shares worth $2.53M. The position accounts for ﹤0.01% of the portfolio, ranked #3393.

Wells Fargo first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Wells Fargo held 170,270 shares of Biohaven worth $2.53M as of Q2 2026.
  • Wells Fargo bought 77,229 Biohaven shares in Q2 2026, an estimated $831K.
  • Biohaven made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #3393 holding.
  • Wells Fargo first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.